SCOPE (Summit for Clinical Operations Executives) 2026
SCOPE brings together the full clinical research ecosystem for four high-impact days of discussion, strategy, and networking. SCOPE is the premier event for clinical trial innovation. In 2026, we’re building on that momentum by expanding coverage of in-demand topics focused on advancing solutions in trial planning, operations, innovation, and investment.
Stop by the Clario booth #916 and find out how we can help simplify your trials with integrated efficacy, safety and quality of life assessments across all phases, therapeutic areas and trial designs.
Clario session information:
Date: Wednesday, February 4, 2026
Time: 8:35 a.m. – 9:00 a.m. ET
Built for Trust: Responsibly Uniting Agentic and Generative AI to Optimize Data Quality and Interpretation of Clinical Outcomes Assessments
The crossroads of data integrity, data consistency, and accurate interpretation are ripe for the application of both agentic and generative AI. Developing and operating such tools requires recognition of potential risks and adherence to a responsible-use framework specifically designed for the clinical trial paradigm. A case-study-based approach will be taken, with real-world examples, demonstrating how novel applications of AI can enhance clinical outcomes assessments, delivering results sponsors and regulators can trust.
Speakers
Todd Rudo, M.D.
Executive Vice President, Chief Medical Officer at Clario
Dr. Todd Rudo is EVP and Chief Medical Officer at Clario, providing medical and scientific leadership across the organization. He has nearly 20 years of clinical cardiology and pharmaceutical research experience, with a career predominantly focused on drug safety. Dr. Rudo has board certifications in cardiology, cardiac electrophysiology, nuclear cardiology, adult echocardiography and internal medicine. His team provides expert consulting to clients on scientific and regulatory strategy, and ensures Clario’s product portfolio is scientifically robust, generating high quality clinical trial endpoint data. Dr. Rudo has a particular interest in applying innovative technologies to improve the scientific rigor of clinical trials, while maintaining focus on the customer experience, including minimizing patient and site burden.
Alex Boudreau
Director of AI at Clario
Alex Boudreau is the Director of AI at Clario. He leads the company’s innovative Generative AI department and oversees the development of the company’s advanced multi-modal GenAI Platform, which encompasses cutting-edge cloud engineering, AI engineering, and foundational AI research. Alex previously pioneered Deep Learning speech analysis systems for automotive applications, led cloud-based enterprise fraud detection solutions, advanced conversational AI technologies, and groundbreaking projects in medical image analysis. His expertise in leading high-impact initiatives positions him uniquely to drive forward the boundaries of AI technology in the business world.
Partner-led sessions information:
Session 1:
Date: Tuesday, February 3, 2026
Time: 4:20 p.m. – 4:45 p.m. ET
Title: From Reactive to Proactive: Integrating Remote Cardiac Safety Monitoring to Enhance Clinical Trial Insights
Track: Digital Endpoints and Biomarkers
Many therapeutic agents including chemotherapeutic drugs, ion channel blockers and nonsteroidal anti-inflammatory drugs (NSAIDs) carry the risk of cardiovascular harm. Traditional practice relies primarily on patient symptoms and scheduled in-clinic checkups. However, this approach can lead to significant delays in detecting asymptomatic ECG abnormalities. Through real-world case studies, we’ll explore potential substantial benefits that this proactive monitoring strategy brings to trials.
Speakers:
- Cecilia Xi, Vice President, Clinical and Scientific Affairs, Vivalink
- Sonia Ortner, Vice President, Digital Endpoint Strategy, Clario
Session 2:
Date: Thursday, February 5, 2026
Time: 10:20 a.m. – 11:00 a.m. ET
Interactive Working Group: Bringing Digital Health Measures to Life in Clinical Development
Discover how digital measures of health are developed and embedded into clinical development programs. Join us for an immersive, hands-on session that goes beyond theory. Through story-driven case studies, gamified panels, and live audience participation, you’ll experience the full journey of integrating digital measures – from concept to implementation.
What to expect:
- Real-world insights from top industry experts
- Experience the process firsthand through interactive, decision-driven scenarios
- Engaging storytelling that makes complex processes come alive
- A chance to collaborate, compete, and co-create in a fun, educational setting
Whether you’re a digital health innovator, clinical strategist, or just curious about the future of clinical trials – this session is your gateway to actionable knowledge and unforgettable engagement.
Speakers:
- Viprali Bhatkar, Senior Director, Global Digital Health Lead, Bristol Myers Squibb
- Bola Grace, PhD, MBA, Senior Director, Digital Biomarkers, GSK; Professor, University College London
- Kai Langel, CEO, DEEP Measures
- Jared Worful, Head, Digital Health Technology, Real-World Science, Bayer
- Sonia Ortner, Vice President, Digital Endpoint Strategy, Clario
Meet with us at SCOPE 2026
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.